No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $24 Price Target
Caribou Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 562.98% HC Wainwright & Co. → $24 Reiterates Buy → Buy 03/19/2024 562.98% HC Wainwright & Co. $
Caribou Biosciences (CRBU) Receives a Buy From Bank of America Securities
Analysts' Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU) and Mettler-Toledo (MTD)
Analysts' Top Healthcare Picks: Caribou Biosciences (CRBU), Lineage Therap (LCTX)
Express News | Caribou Biosciences Inc : Truist Securities Cuts Target Price to $19 From $21